Evidence map›Paper›PMID 32078493›Full record

Trial reportStroke2020

Fixed Compared With Autoregulation-Oriented Blood Pressure Thresholds After Mechanical Thrombectomy for Ischemic Stroke.

Nils H Petersen, Andrew Silverman, Sumita M Strander, Sreeja Kodali, Anson Wang, Lauren H Sansing, Joseph L Schindler, Guido J Falcone, Emily J Gilmore, Adam S Jasne and 5 more

2 registry-linked trialsOpen access · greenAbstract readClinical Trial
In one paragraph

Trial report in Stroke, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 2 registered trials, which are not on this map. Cited by 63 papers, 5 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
63citing papers in PubMed, 5 pooled it
9.2field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05155852 completednot on this mapstarted 2021, after this paper: background citation

NIRS-Based Bedside Monitoring to Identify Impaired Cerebral Autoregulation in Women with Postpartum Hypertension

TypeobservationalSponsorColumbia UniversityRan2021 to 2023Enrolled5ConditionsPreeclampsia, Hypertension in Pregnancy
NCT05670028 phase2unknown statusnot on this mapstarted 2023, after this paper: background citation

Cerebral Hemodynamic Management Based on Cerebral Autoregulation Monitoring in Acute Ischemic Stroke Patients After Endovascular Treatment: a Multicenter, Open-label, Randomized Control Study

TypeinterventionalSponsorBeijing Tiantan HospitalRan2023 to 2026Enrolled100ConditionsIschemic Stroke, Revascularization, Blood Pressure, Cerebrovascular InsufficiencyArmsHypotensive Drugs and/or Vasoactive Drugs
3 · Its place in the literature

Who cites it

63 citing papers in PubMed, 5 syntheses or guidelines pooled it, 103 citations in OpenAlex.

  1. Guideline
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Trial
  7. Article
  8. Article
  9. Article
  10. Article
  11. Observational
  12. Article
  13. Observational
  14. Article
  15. Observational
  16. Review
  17. Review
  18. Individualized autoregulation-guided arterial blood pressure management in neurocritical care.Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics · 2025
    Review
  19. Article
  20. Review

3 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 2 institutions in 2 countries.

Nils H PetersenFrom the Department of Neurology (N.H.P., A.S., S.M.S., S.K., A.W., L.H.S., J.L.S., G.J.F., E.J.G., A.S.J., K.N.S.), Yale University School of Medicine, New Haven, CT.
Andrew SilvermanFrom the Department of Neurology (N.H.P., A.S., S.M.S., S.K., A.W., L.H.S., J.L.S., G.J.F., E.J.G., A.S.J., K.N.S.), Yale University School of Medicine, New Haven, CT.
Sumita M StranderFrom the Department of Neurology (N.H.P., A.S., S.M.S., S.K., A.W., L.H.S., J.L.S., G.J.F., E.J.G., A.S.J., K.N.S.), Yale University School of Medicine, New Haven, CT.
Sreeja KodaliFrom the Department of Neurology (N.H.P., A.S., S.M.S., S.K., A.W., L.H.S., J.L.S., G.J.F., E.J.G., A.S.J., K.N.S.), Yale University School of Medicine, New Haven, CT.
Anson WangFrom the Department of Neurology (N.H.P., A.S., S.M.S., S.K., A.W., L.H.S., J.L.S., G.J.F., E.J.G., A.S.J., K.N.S.), Yale University School of Medicine, New Haven, CT.
Lauren H SansingFrom the Department of Neurology (N.H.P., A.S., S.M.S., S.K., A.W., L.H.S., J.L.S., G.J.F., E.J.G., A.S.J., K.N.S.), Yale University School of Medicine, New Haven, CT.
Joseph L SchindlerFrom the Department of Neurology (N.H.P., A.S., S.M.S., S.K., A.W., L.H.S., J.L.S., G.J.F., E.J.G., A.S.J., K.N.S.), Yale University School of Medicine, New Haven, CT.
Guido J FalconeFrom the Department of Neurology (N.H.P., A.S., S.M.S., S.K., A.W., L.H.S., J.L.S., G.J.F., E.J.G., A.S.J., K.N.S.), Yale University School of Medicine, New Haven, CT.
Emily J GilmoreFrom the Department of Neurology (N.H.P., A.S., S.M.S., S.K., A.W., L.H.S., J.L.S., G.J.F., E.J.G., A.S.J., K.N.S.), Yale University School of Medicine, New Haven, CT.
Adam S JasneFrom the Department of Neurology (N.H.P., A.S., S.M.S., S.K., A.W., L.H.S., J.L.S., G.J.F., E.J.G., A.S.J., K.N.S.), Yale University School of Medicine, New Haven, CT.
Branden CordDepartment of Neurosurgery (B.C., R.M.H., C.C.M.), Yale University School of Medicine, New Haven, CT.
Ryan M HebertDepartment of Neurosurgery (B.C., R.M.H., C.C.M.), Yale University School of Medicine, New Haven, CT.
Michele JohnsonDepartment of Radiology (M.J.), Yale University School of Medicine, New Haven, CT.
Charles C MatoukDepartment of Neurosurgery (B.C., R.M.H., C.C.M.), Yale University School of Medicine, New Haven, CT.
Kevin N ShethFrom the Department of Neurology (N.H.P., A.S., S.M.S., S.K., A.W., L.H.S., J.L.S., G.J.F., E.J.G., A.S.J., K.N.S.), Yale University School of Medicine, New Haven, CT.
Norwegian Womens Public Health Association · NOYale University · US

Funding

Yale Clinical and Translational Science Award (U Component)UL1TR001863 · NCATS · YALE UNIVERSITY · PI John H. Krystal, LUCILA OHNO-MACHADO · 2016 to 2026
$102.9M
Yale Study Support Suite (YES3): Dashboard and Web Portal Software Supporting Research Workflow through integrated, customizable REDCap External ModulesP30AG021342 · NIA · YALE UNIVERSITY · PI Albert C Shaw · 2002 to 2026
$37.9M
Anticoagulation in ICH Survivors for Prevention and Recovery (ASPIRE)U01NS106513 · NINDS · YALE UNIVERSITY · PI Hooman Kamel, Kevin Navin Sheth · 2019 to 2026
$20.6M
Institutional Career Development CoreKL2TR001862 · NCATS · YALE UNIVERSITY · PI CANTLEY, LLOYD G, EDELMAN, E. JENNIFER · 2016 to 2025
$12.2M
Cerebrovascular Fellowship Training ProgramT32NS047996 · NINDS · UNIVERSITY OF CINCINNATI · PI Joseph Paul Broderick, Stacie Demel · 2006 to 2026
$3.7M
The Recovery in Stroke Using PAP (RISE UP) StudyR01NR018335 · NINR · YALE UNIVERSITY · PI REDEKER, NANCY S, SHETH, KEVIN NAVIN · 2019 to 2023
$3.4M
Southern New England Partnership In Stroke Research, Innovation and Treatment (SPIRIT)U24NS107215 · NINDS · YALE UNIVERSITY · PI MARK Jay ALBERTS, Karen L Furie · 2018 to 2026
$3.0M
Yale Clinical Site: Investigations For Improved Neurological Treatments at Yale (INFINITY)U24NS107136 · NINDS · YALE UNIVERSITY · PI SHETH, KEVIN NAVIN, SPUDICH, SERENA S · 2018 to 2022
$1.7M
Precision blood pressure management after endovascular stroke therapy based on real-time autoregulation measurementsK23NS110980 · NINDS · YALE UNIVERSITY · PI PETERSEN, NILS H. · 2020 to 2024
$951k
Intensive Blood Pressure Reduction in Deep Intracerebral HemorrhageR03NS112859 · NINDS · YALE UNIVERSITY · PI FALCONE, GUIDO JOSE, SHETH, KEVIN NAVIN · 2019 to 2020
$84k
NCATS NIH HHS KL2 TR001862NCATS NIH HHS UL1 TR001863NIA NIH HHS K76 AG059992NIA NIH HHS P30 AG021342NINDS NIH HHS K23 NS110980NINDS NIH HHS R03 NS112859NINDS NIH HHS T32 NS047996NINDS NIH HHS U01 NS106513NINDS NIH HHS U24 NS107136NINDS NIH HHS U24 NS107215NINR NIH HHS R01 NR018335
6 · The paper itself

Abstract

Background and Purpose- Loss of cerebral autoregulation in the acute phase of ischemic stroke leaves patients vulnerable to blood pressure (BP) changes. Effective BP management after endovascular thrombectomy may protect the brain from hypoperfusion or hyperperfusion. In this observational study, we compared personalized, autoregulation-based BP targets to static systolic BP thresholds. Methods- We prospectively enrolled 90 patients undergoing endovascular thrombectomy for stroke. Autoregulatory function was continuously measured by interrogating changes in near-infrared spectroscopy-derived tissue oxygenation (a cerebral blood flow surrogate) in response to changes in mean arterial pressure. The resulting autoregulatory index was used to trend the BP range at which autoregulation was most preserved. Percent time that mean arterial pressure exceeded the upper limit of autoregulation or decreased below the lower limit of autoregulation was calculated for each patient. Time above fixed systolic BP thresholds was computed in a similar fashion. Functional outcome was measured with the modified Rankin Scale at 90 days. Results- Personalized limits of autoregulation were successfully computed in all 90 patients (age 71.6±16.2, 47% female, mean National Institutes of Health Stroke Scale 13.9±5.7, monitoring time 28.0±18.4 hours). Percent time with mean arterial pressure above the upper limit of autoregulation associated with worse 90-day outcomes (odds ratio per 10% 1.84 [95% CI, 1.3-2.7]

Indexed as

Blood PressureBrain IschemiaCerebrovascular CirculationHomeostasisModels, CardiovascularStrokeThrombectomyAgedAged, 80 and overFemaleHumansMaleMiddle AgedProspective Studiesarterial pressureblood pressurebrainhemorrhagethrombectomy

Identifiers

PMID32078493
PMCPMC7050651
OpenAlexW3005661879

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.